{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-032732","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2025-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.513137+00:00","generated_at":"2026-05-23T12:26:59.432716+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Cadrenal Therapeutics files ATM prospectus supplement for up to 2.17M shares; $7.7M already sold","bullets":["Filed prospectus supplement to sell up to 2,169,272 shares of common stock via ATM program with H.C. Wainwright.","Company had sold $7,655,240 in common stock under the existing ATM agreement as of the filing date.","Wainwright earns 3.0% commission on gross proceeds from any sales under the ATM agreement.","Company may suspend or terminate the offering at any time; no obligation to sell shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-032732","json":"https://secwatch.observer/filing/0001213900-25-032732.json","markdown":"https://secwatch.observer/filing/0001213900-25-032732.md","text":"https://secwatch.observer/filing/0001213900-25-032732.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025032732/0001213900-25-032732-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025032732/ea0238567-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T12:26:59.432716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}